Previous close | 82.32 |
Open | 86.21 |
Bid | 0.00 x 900 |
Ask | 0.00 x 800 |
Day's range | 84.74 - 87.32 |
52-week range | 81.37 - 233.14 |
Volume | 696,196 |
Avg. volume | 347,640 |
Market cap | 5.626B |
Beta (5Y monthly) | 0.28 |
PE ratio (TTM) | N/A |
EPS (TTM) | -1.69 |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 94.67 |
NEW YORK, March 3, 2021 /CNW/ -- Pomerantz LLP is investigating claims on behalf of investors of Galapagos NV ("Galapagos" or the "Company") (NASDAQ: GLPG). Such investors are advised to contact Robert S.
Despite some serious setbacks, this beaten-down biotech could be a terrific bargain at recent prices.
GLPG earnings call for the period ending December 31, 2020.